Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.28%
1,085.81
+3.01
+0.28%
—1,082.801,079.311,090.181,079.31——
SIXC
Communications
SIXC
Communications
SIXC
+0.65%
607.69
+3.92
+0.65%
—603.77603.77611.65602.09——
SIXE
Energy
SIXE
Energy
SIXE
-1.55%
1,192.38
-18.81
-1.55%
—1,211.191,203.051,203.481,182.72——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.02%
1,756.39
+0.40
+0.02%
—1,755.991,759.061,761.741,747.23——
SIXM
Financials
SIXM
Financials
SIXM
-0.82%
633.27
-5.24
-0.82%
—638.51637.93640.10631.89——
SIXR
Staples
SIXR
Staples
SIXR
+1.12%
852.42
+9.46
+1.12%
—842.96843.54858.44843.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.22%
218.79
-0.49
-0.22%
—219.28219.28220.58218.64——
SIXT
Technology
SIXT
Technology
SIXT
-0.45%
3,711.69
-16.66
-0.45%
—3,728.353,745.063,745.063,675.02——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.48%
911.05
-4.43
-0.48%
—915.48914.49915.84907.90——
SIXV
Health care
SIXV
Health care
SIXV
+0.22%
1,500.66
+3.30
+0.22%
—1,497.361,500.651,514.701,495.89——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.73%
2,454.96
+41.79
+1.73%
—2,413.172,431.692,463.522,431.69——
217730:KOSDAQ
Kang Stem Biotech Co Ltd
â‚©3,115.00
-3.26%
(-105.00) 1D
May 27, 3:30:20 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 217730...
Open
â‚©3,190
High
â‚©3,215
Low
â‚©2,990
Mkt. cap
292.98B
Avg. vol.
1.50M
Volume
578.01K
52-wk high
â‚©4,690
52-wk low
â‚©1,080
EPS
-â‚©144
Shares outstanding
94.05M
No. of employees
86
News stories
From sources across the web
About Kang Stem Biotech Co Ltd
CEOJong Cheon Na
Employees86
Founded2010
Headquarters-
SectorBiotechnology
Websitekangstem.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2024
Dec 2024
Mar 2025
Mar 2026
Revenue
783.33M
3.40B
954.35M
805.01M
Cost of goods sold
417.78M
903.59M
748.72M
839.30M
Cost of revenue
417.78M
903.59M
748.72M
839.30M
Research and development expenses
2.86B
3.19B
3.23B
2.95B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.47B
1.85B
1.69B
1.55B
Operating expense
4.35B
5.03B
4.95B
4.54B
Total operating expenses
4.77B
5.93B
5.70B
5.37B
Operating income
-3.98B
-2.53B
-4.74B
-4.57B
Other non operating income
12.39M
75.77M
16.96M
3.70M
EBT including unusual items
-4.03B
-4.28B
-4.90B
-4.56B
EBT excluding unusual items
-3.72B
-2.30B
-4.68B
-4.47B
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.03B
-4.38B
-4.90B
-4.56B
Net profit margin
-514.53%
-128.66%
-513.76%
-566.56%
Earnings per share
-
-
-
-
Interest and investment income
361.66M
272.93M
174.73M
238.68M
Interest expense
-114.52M
-118.31M
-127.00M
-124.26M
Net interest expenses
247.14M
154.62M
47.73M
114.42M
Depreciation and amortization charges
7.28M
-10.25M
21.09M
28.77M
EBITDA
-3.31B
-1.75B
-4.06B
-4.07B
Gain or loss from assets sale
-
40.10M
6.50M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer